Online Program

Promoting the adoption of smoke-free policies in multi-unit housing: An intervention

Tuesday, November 3, 2015

Karen Palmersheim, PhD, MS, MSW, BS, Center for Urban Initiatives and Research, University of Wisconsin, Milwaukee, WI
Terry Batson, MA, Center for Urban Initiatives and Research, University of Wisconsin, Milwaukee, WI
Lynn Hrabik, MPH, RD, CD, Wisconsin Clearinghouse for Prevention Resources, University of Wisconsin - Madison, Pulaski, WI
Luongo Sarah, BA, Center for Urban Initiatives and Research, University of Wisconsin, Milwaukee, WI
Randall Glysch, MS, Tobacco Prevention and Control Program, Wisconsin Division of Public Health, Madison, WI
Background:  During Fall, 2011, the US Centers for Disease Control and Prevention awarded the Community Transformation Grant (CTG) with the purpose of building community capacity to prevent chronic disease.  Funds supported communities as they pursued evidence-based strategies to prevent obesity, reduce tobacco use, and improve screening for high blood pressure and cholesterol.  Wisconsin was awarded a multi-year CTG.

Wisconsin's initiative focused on changing systems and policies that create opportunities to make healthy choices in three important areas: tobacco-free living, healthy food systems, and active communities.  Thirty Wisconsin communities (grantees) received funding to support these efforts.  The purpose of this session is to discuss the intervention strategies, and to share the findings of the evaluation conducted in the tobacco-free living arm of the initiative.

The Intervention:  Grantees worked with owners and operators of multi-unit housing buildings in their communities with the goal of encouraging them to voluntarily adopt smoke-free policies for their buildings.  Grantees enlisted the use of multiple strategies, and worked with various persons at both the individual and organizational level.

 The Evaluation:  The evaluation consisted of a quasi-experimental design, with a treatment group (communities targeted for intervention as part of the CTG project) and a comparison group (matched communities that were not part of the CTG project).  Baseline and follow-up data collection was conducted via telephone interviews, mailed surveys, and performance-based instruments completed by grantees in each targeted community.

This session will discuss the intervention strategies, the evaluation research design and data collection instruments, and the findings of the evaluation.  Intervention strategies that were most successful will be discussed, along with strengths and challenges associated with various aspects of the evaluation.

Learning Areas:

Chronic disease management and prevention
Conduct evaluation related to programs, research, and other areas of practice
Environmental health sciences
Implementation of health education strategies, interventions and programs
Public health or related research

Learning Objectives:
List the intervention strategies associated with the successful adoption of smoke-free policies among owners and operators of multi-unit housing buildings. Discuss the importance of conducting quality evaluation research on public health promotion initiatives. Demonstrate how to design a quasi-experimental evaluation. Identify the strengths and challenges of conducting a quasi-experimental evaluation.

Keyword(s): Evaluation, Tobacco Control

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked as a researcher, epidemiologist, program director, and principal investigator in the area of tobacco surveillance and evaluation research for 12 years. I have experience in all aspects of the research process: proposal development, methodological design, literature review, survey instrument construction, data analysis, report and manuscript writing, and presentation of findings to stakeholders and at professional conferences. Much of my work has been conducted in collaboration with the Wisconsin Division of Public Health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.